Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Myelocytic, Chronic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05362773
What this trial is testing

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics 130
Early research (Phase 1)Study completedNCT04126707
What this trial is testing

The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans

Who this might be right for
Chronic Myeloid Leukemia (CML)
Ascentage Pharma Group Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00047021
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT00996047
What this trial is testing

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)Study completedNCT01744665
What this trial is testing

A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation

Who this might be right for
CML
Novartis Pharmaceuticals 59
Early research (Phase 1)Study completedNCT00867230
What this trial is testing

FTS Study in Patients With Advanced Hematologic Malignancies

Who this might be right for
Myelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT04709731
What this trial is testing

Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia (CML)
Associazione Italiana Pazienti Leucemia Mieloide Cronica 50
Testing effectiveness (Phase 2)Study completedNCT00006019
What this trial is testing

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
LeukemiaLung CancerLymphoma+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00006239
What this trial is testing

Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT01629082
What this trial is testing

Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myeldysplastic Syndrome (MDS)Chronic Myelomonocytic LeukemiaBone Marrow Diseases+2 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Not applicableStudy completedNCT01437202
What this trial is testing

Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Asan Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT04943757
What this trial is testing

Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies

Who this might be right for
Myeloid Leukemia, AcuteChronic Myeloid LeukemiaMyelodysplastic Syndromes+1 more
St. Petersburg State Pavlov Medical University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862157
What this trial is testing

Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Eosinophilic Leukemia, Not Otherwise Specified+13 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00003239
What this trial is testing

Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 90
Not applicableLooking for participantsNCT05702645
What this trial is testing

Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia Associated With Down SyndromeDown SyndromeMyeloid Leukemia Associated With Down Syndrome
Children's Oncology Group 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07719348
What this trial is testing

Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome Acute Myeloid Leukemia
Servier 64
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00219752
What this trial is testing

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

Who this might be right for
Chronic Myeloid Leukemia
Poitiers University Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515
What this trial is testing

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 170
Next Page